|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 519/00 | (2006.01) |
| A61K 31/439 | (2006.01) | ||
| A61P 1/04 | (2006.01) |
| (11) | Number of the document | 3303348 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16728495.9 |
| Date of filing the European patent application | 2016-05-26 | |
| (97) | Date of publication of the European application | 2018-04-11 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-07 |
| (46) | Date of publication of the claims translation | 2019-11-25 |
| (86) | Number | PCT/US2016/034243 |
| Date | 2016-05-26 |
| (87) | Number | WO 2016/191524 |
| Date | 2016-12-01 |
| (30) | Number | Date | Country code |
| 201562167694 P | 2015-05-28 | US | |
| 201662312273 P | 2016-03-23 | US |
| (72) |
HUDSON, Ryan, US
KOZAK, Jennifer, US
FATHEREE, Paul R., US
PODESTO, Dante D., US
BRANDT, Gary E.L., US
FLEURY, Melissa, US
BEAUSOLEIL, Anne-Marie, US
HUANG, Xiaojun, US
THALLADI, Venkat R., US
|
| (73) |
Theravance Biopharma R&D IP, LLC,
901 Gateway Boulevard, South San Francisco, CA 94080,
US
|
| (74) |
Otilija KLIMAITIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Naftiridino junginiai, kaip JAK kinazės inhibitoriai |
| NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2022-05-03 | 7 | 162.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-05-26 |